Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Amneal Pharmaceuticals Inc. Class A logo

Amneal Pharmaceuticals Inc. Class A

Sector: Healthcare   

Industry: Drug Manufacturers - Specialty & Generic

Optionable: Yes  Market Cap: 2,114 M  90-day average vol: 1,629,030

Previous close: 6.75  Open: 6.73  Bid: 6.75  Ask: 6.85
52 week range    
OGN / 
Last updated: Monday 20th May 2024
MarketXLS Rank

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord


AMRX Income Statement

Invalid dateDec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
AccretionOnPreferredStock-375 M1 M438000.0
AccruedPreferredStockDividends168 M-149 M
AcquisitionExpense16 M9 M8 M700000.0
Amortization of intangibles-4 M-73 M1,383 M1,305 M1,167 M1,096 M890 M
Basic EPS from continuing operations-2.740.620.07-0.86-0.48
Basic EPS total-0.07-2.740.620.07-0.86-0.48
Basic weighted shares outstanding127 M132 M147 M149 M151 M176 M
Cost of sales-507 M-939 M1,147 M1,330 M1,302 M1,428 M1,573 M
Depreciation-42 M-64 M63 M60 M61 M68 M66 M
DepreciationAndAmortization-42 M-64 M63 M60 M61 M68 M66 M
Diluted EPS total-0.16-2.740.610.07-0.86-0.48
Diluted normalized net income/share0.610.07-0.86-0.48
Diluted weighted shares outstanding136 M149 M152 M151 M176 M
Fees-2 M
GainOnSaleOfSecurity-29 M-3 M
GainsLossOnDisposalOfDiscontinuedOperations7 M123000.0
GeneralAndAdministrativeExpense-17 M-18 M290 M327 M366 M400 M430 M
Gross operating profit526 M716 M479 M663 M792 M785 M821 M
ImpairmentOfCapitalAssets-4 M39 M47 M3 M710000.013 M31 M
Income before tax171 M-203 M-220 M-36 M31 M-248 M-40 M
Income restructuring and M&A56 M34 M2 M2 M1 M2 M
Income taxes2 M-1 M383 M-104 M11 M7 M9 M
Interest income-71 M-142 M-168 M-146 M-136 M-158 M-211 M
InterestExpenseNonOperating-1 M5 M5 M5 M5 M5 M
InterestExpenseOperating2 M
MinorityInterests-2 M33 M242 M22 M-10 M125 M-35 M
MiscOtherSpecialCharges-3 M-19 M194 M3 M15 M18 M-36 M
Net income from total operations169 M-22 M-362 M91 M11 M-130 M-84 M
NetIncomeCommonStockholders1 M-23 M-362 M91 M11 M-130 M-84 M
NetIncomeContinuousOperations169 M-22 M-362 M91 M11 M-130 M-84 M
NetIncomeDiscontinuousOperations7 M123000.0
NetIncomeFromOtherGainsLosses149 M
NetNonOperatingInterestIncomeExpense-70 M-142 M-168 M-146 M-136 M-158 M-211 M
NonRecurringOperationExpense-9 M-20 M12 M6 M25 M270 M2 M
Normalized income68 M
Operating income236 M56 M-249 M91 M153 M-95 M204 M
Operating income before depreciation (EBITDA)221 M-47 M35 M213 M279 M5 M202 M
OperatingExpense290 M660 M475 M508 M562 M597 M596 M
Other income net32 M22 M-194 M-3 M-15 M-17 M21 M
Other special charges-4 M-1 M
OtherGandA-17 M-18 M290 M327 M366 M400 M430 M
OtherImpairmentOfCapitalAssets2 M1000000.024 M67 M
OtherOperatingExpenses16 M14 M11 M8 M398000.03 M
OtherunderPreferredStockDividend168 M1 M438000.0
PreferredStockDividends168 M1 M438000.0
RentAndLandingFees-17 M-18 M
Research & development expense171 M194 M188 M180 M202 M196 M164 M
ResearchExpense171 M194 M188 M180 M202 M196 M164 M
RestructringAndMnAIncome56 M34 M2 M2 M1 M2 M
Revenue per share-9 M-79 M1,389 M1,313 M1,172 M1,101 M895 M
SalariesAndWages9 M222 M-16 M-9 M-13 M1 M
Selling Gen & administrative expense109 M228 M290 M327 M366 M400 M430 M
SellingAndMarketingExpense109 M228 M
SellingExpense109 M228 M
Special income/charges9 M-76 M-93 M-11 M-28 M-284 M-34 M
Total Income available for interest expense (EBIT)170 M-201 M-216 M-31 M36 M-244 M-36 M
Total common shares outstanding1000.0299 M299 M300 M302 M304 M307 M
Total net income169 M-22 M-362 M91 M11 M-130 M-84 M
Total ordinary shares307 M307 M307 M307 M307 M307 M307 M
Total revenues1,034 M1,655 M1,753 M2,027 M2,116 M2,212 M2,394 M
TotalExpenses-218 M-279 M1,623 M1,838 M1,864 M2,025 M2,169 M
TotalRevenue1,034 M1,663 M1,626 M1,993 M2,094 M2,212 M2,394 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu


I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.


Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University